Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma

NCT00456716 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: sorafenib

Sponsor

Swedish Medical Center

Collaborators

[object Object]
[object Object]